The Central Drugs Standard Control Organisation (CDSCO) has issued a Public Notice regarding the Compounding of Offences under the Drugs and Cosmetics Act, 1940, based on the newly notified Drugs and Cosmetics (Compounding of Offences) Rules, 2025. This notice…
07th November 2025 The Central Drugs Standard Control Organisation (CDSCO) has issued a directive to all State Licensing Authorities (SLAs) to conduct inspections of pharmaceutical manufacturing firms in accordance with the Revised Schedule M requirements. As per the notice…
07th September, 2025 The Central Drugs Standard Control Organization (CDSCO) has released an important regulatory update regarding the approval process for combi-pack products—specifically combinations of lyophilized powders for injection or IV infusion with diluents like Sterile Water for Injection (SWFI)…
13th September,2025 The Government of India has just announced a significant change that will impact the pharmaceutical and medical devices industry, effective “22nd September 2025”. Yes, you read that right—GST rates on drugs, formulations, and medical devices are being reduced,…
5th August, 2025 The Ministry of Health and Family Welfare has issued G.S.R. 513(E) dated 29th July 2025, announcing pivotal amendments to the Cosmetics Rules, 2020 under the Drugs and Cosmetics Act, 1940. These changes aim to strengthen the regulatory…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
